Company: GNMSF
Filing Date: 2025-08-07
Form Type: 6-K
Source: 0001434265-25-000063
Chunk: 44

Company: GENMAB A/S
Filing Date: 2025-08-07
Form: 6-K
Chunk 44
---
2023.

Contract Liabilities

As part of the continued evaluation of contract liabilities related to the AbbVie Agreement, during the first six months of 2025, Genmab’s classification of contract liabilities reflects the current estimate of co-development activities as of June 30, 2025. These co-development activities are related to a performance obligation in connection with the product concepts under a research option agreement. Contract liabilities have been recognized as reimbursement revenue during the first half of 2025.

Refer to Note 2.1 in the Annual Report for further details regarding revenue.

Note 4 - Other Intangible Assets and Goodwill

| June 30, 2025                                                     |     | Goodwill |     |     | Licenses and Patents |     |     | Technology Platform |     |     | Acquired IPR&D |       |     | Total Intangible Assets |       |
|:------------------------------------------------------------------|:----|:---------|----:|:----|:---------------------|----:|:----|:--------------------|----:|:----|:---------------|------:|:----|:------------------------|------:|
| Cost at the beginning of the period                               |     | $        | 355 |     | $                    | 149 |     | $                   | 180 |     | $              | 1,532 |     | $                       | 2,216 |
| Additions during the period                                       |     |          |   — |     |                      |  32 |     |                     |   — |     |                |     — |     |                         |    32 |
| Cost at the end of the period                                     |     | $        | 355 |     | $                    | 181 |     | $                   | 180 |     | $              | 1,532 |     | $                       | 2,248 |
| Amortization and impairment losses at the beginning of the period |     |          |   — |     |                      | 126 |     |                     |   7 |     |                |     — |     |                         |   133 |
| Amortization for the period                                       |     |          |   — |     |                      |   1 |     |                     |   6 |     |                |     — |     |                         |     7 |
| Impairment losses for the period                                  |     |          |   — |     |                      |   1 |     |